Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Sep 6;6:113. doi: 10.1038/s41541-021-00376-7

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2021

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Fig. 5 — a Number of individuals of each inferred IGHV1-2 genotype in the collective cohort (left) and within each population subgroup (right), based on allele inferences made using RNA-seq data (n = 75 donors). b Number of individuals of each IGHV1-2 genotype based on inferences made from IgM/IgD expressed antibody RepSeq data (n = 84 donors). c IGHV1-2 gene usage within the IgM/IgD repertoire partitioned by IGHV1-2 genotype (n = 83 donors). d IGHV1-2 gene usage in the IgM/IgD repertoire partitioned by genotypes at SNPs rs112806369 and rs1065059 (n = 83 donors). e IGHV1-2 allele-specific usage within the IgM/IgD repertoire in IGHV1-2 heterozygotes (*02/*04, n = 28 donors; *02/*06, n = 6; *04/*06, n = 14). All boxplots are plotted as follows: center line, median; box limits, upper and lower quartiles; whiskers, 1.5× interquartile range; points outside the whiskers, outliers. One-way ANOVA: ***P < 0.0001; ****P < 0.00001; ns not significant.